Work

Supplementary Figures S1 - S11 from Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure S1. Functional modules among 384 genes selected for the NMF algorithm. Supplementary Figure S2. Co-occurring somatic mutations in KRAS-mutant LUAC subgroups. Supplementary Figure S3. Distribution of bi-allelic deletion/amplification events in the three KRAS-mutant LUAC subsets. Supplementary Figure S4. Alterations in genes involved in G1/S transition in the three KRAS-mutant LUAC subgroups. Supplementary Figure S5. Clonal fractions for somatically mutated genes in the 68 KRAS-mutant LUACs (TCGA). Supplementary Figure S6. Co-mutation plot for the combined PROSPECT/CHITALE validation dataset of chemotherapy -naïve KRAS-mutant LUACs. Supplementary Figure S7. Co-occurring genetic events in PI3K-AKT-MTOR pathway genes in the three KRAS-mutant LUAC subsets. Supplementary Figure S8. LKB1-loss-dependent up-regulation of adaptive branches of the unfolded protein response in KRAS-mutant LUAC cell lines. Supplementary Figure S9. Enumeration of distinct immune cell populations in the KRAS LUAC sub-groups from PROSPECT. Supplementary Figure S10. Analysis of overall survival (OS) in KRAS-mutant LUAC subsets. Supplementary Figure S11. Integrated analyses for a higher pre-determined number of KRAS-mutant LUAC subsets.
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4362531344
Cites:
Cited by:
Related to: 10